[HTML][HTML] Coronavirus disease 2019 (COVID-19): latest developments in potential treatments

KL Hon, KKY Leung, AKC Leung, SY Qian… - Drugs in …, 2020 - ncbi.nlm.nih.gov
Many viral respiratory infections can cause severe acute respiratory symptoms leading to
mortality and morbidity. In the spring of 2003, the severe acute respiratory syndrome (SARS) …

[PDF][PDF] An update on the status of COVID-19: a comprehensive review.

N Zhao, ZL Zhou, L Wu, XD Zhang… - European Review for …, 2020 - europeanreview.org
The last two decades have witnessed two large-scale pandemics caused by coronaviruses,
including severe acute respiratory syndrome (SARS) and the Middle East respiratory …

COVID-19: epidemiology, pathology, diagnosis, treatment, and impact

S Shahriar, MS Rana, MS Hossain… - Current …, 2021 - ingentaconnect.com
The pandemic, well-known as COVID-19, has been caused by the coronavirus SARS-CoV-2
and it has distinct characteristics from other coronavirus-related epidemics. This pandemic …

An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

Therapeutic options for COVID-19: a quick review

MS Ismaila, F Bande, A Ishaka, AA Sani… - Journal of …, 2020 - Taylor & Francis
Since the announcement by the World Health Organization (WHO) of an outbreak of a
contagious respiratory viral pneumonia in Wuhan, China, in December 2019 (later named …

[HTML][HTML] Current treatment in COVID-19 disease: a rapid review

M Rodriguez-Guerra, P Jadhav, TJ Vittorio - Drugs in context, 2021 - ncbi.nlm.nih.gov
The world has faced the most challenging pandemic of the modern era, that of severe acute
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …

Current pharmacological treatments for SARS-COV-2: A narrative review

G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …

Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19

MII Rabby - Journal of pharmacy & pharmaceutical …, 2020 - journals.library.ualberta.ca
Purpose: SARS-CoV-2 first emerged in China in December 2019 and rapidly spread
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …

Effectiveness of remdesivir, lopinavir/ritonavir, and favipiravir for COVID-19 treatment: a systematic review

WF Qomara, DN Primanissa, SH Amalia… - … journal of general …, 2021 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …

[HTML][HTML] Therapeutic options for COVID-19: a review

R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - ncbi.nlm.nih.gov
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …